Azido-PEG3-Val-Cit-PAB-OH is a cleavable ADC linker with Val-Cit dipeptide and PAB spacer for enzymatic release, combined with azide and PEG3 for hydrophilicity and click chemistry bioconjugation.
Structure of 2055024-65-0
* For research and manufacturing use only. We do not sell to patients.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Azido-PEG3-Val-Cit-PAB-OH, a versatile linker molecule extensively utilized in the biosciences, offers a myriad of applications in drug delivery and bioconjugation. Here are four key applications presented with a high degree of perplexity and burstiness:
Antibody-Drug Conjugates (ADCs): Serving as a pivotal component in the synthesis of antibody-drug conjugates, Azido-PEG3-Val-Cit-PAB-OH acts as a cleavable linker that intricately connects the antibody and cytotoxic drug. This intricate design ensures the precise release of the drug within target cells upon internalization, enhancing the specificity and potency of cancer therapies. By minimizing off-target effects and maximizing therapeutic outcomes, this innovative approach revolutionizes the landscape of cancer treatment.
Prodrug Development: Embracing the concept of prodrug development, this versatile linker molecule plays a pivotal role in connecting the active drug molecule to a carrier, thereby enhancing solubility and stability. Upon reaching the desired target site, the linker undergoes cleavage, releasing the active drug and facilitating optimal drug delivery and bioavailability. This strategic approach transforms the field of drug development, fostering more efficacious treatments across various medical conditions.
Targeted Drug Delivery: Taking the lead in targeted drug delivery systems, Azido-PEG3-Val-Cit-PAB-OH contributes to the creation of nanoparticles and liposomes by attaching targeting ligands. This innovative approach enhances the precision of therapeutic delivery to specific cells or tissues, such as tumor sites or inflammatory regions, while simultaneously reducing systemic side effects. By optimizing the delivery mechanism, this cutting-edge technology elevates treatment efficacy and patient outcomes.
Bioconjugation: The presence of the azido group within Azido-PEG3-Val-Cit-PAB-OH facilitates click chemistry-based bioconjugation, a crucial process for attaching biomolecules to surfaces, drug carriers, or other macromolecules. This streamlined approach enables the development of multifunctional biomaterials and advanced diagnostic tools, propelling bioscience research forward. The efficiency and simplicity of bioconjugation techniques streamline experimental procedures, ushering in a new wave of innovative applications in the realm of biochemistry and molecular biology.
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.